Physician

David Matthew Paxton, MD

According to 2025 Medicare claims, David Paxton, MD (NPI: 1578940649) practices family practice in the Wheeling, WV-OH market, with the plurality of this provider's patient population coming from Ohio, WV. This provider's primary affiliated billing organization is WHEELING HOSPITAL INC (NPI: 1548923923; TIN: 55-0357057) and primary practice location at 26003-5083. Paxton is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Paxton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 318 traditional Medicare patients, billed 3,058 HCPCS/CPT codes, and received $94,406 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 10,795 prescription claims across 709 beneficiaries totaling $1,200,250 in drug costs, led by Ozempic (Semaglutide). DME data shows 355 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $8,429 to $94,406. Similarly, Part D prescription costs have moved sharply higher in recent years, from $11,664 to $1,200,250. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $102 to $19,521.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	116	199	$8,429
2019	291	848	$32,263
2020	334	1,952	$74,087
2021	312	1,497	$76,577
2022	308	1,751	$107,045
2023	310	1,834	$102,967
2024	318	3,058	$94,406

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	32	149	$11,664
2016	61	862	$65,604
2017	99	1,200	$96,124
2018	314	1,581	$108,378
2019	490	5,816	$435,144
2020	568	7,278	$582,459
2021	607	8,164	$799,944
2022	645	8,415	$938,527
2023	674	9,955	$1,188,606
2024	709	10,795	$1,200,250

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	13	$183
2019	15	67	$554
2020	30	196	$6,551
2021	31	222	$6,666
2022	26	311	$11,924
2023	12	237	$12,652
2024	135	355	$919,860

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	144	144	$120
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	202	369	$75
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	176	274	$54
G0008	Administration of influenza virus vaccine	85	88	$30
36415	Insertion of needle into vein for collection of blood sample	112	142	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	131	5,308	$173,622
Eliquis	Apixaban	192	8,155	$155,255
Jardiance	Empagliflozin	90	5,550	$106,268
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	121	4,170	$86,901
Farxiga	Dapagliflozin Propanediol	82	4,460	$80,053

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4353	Intermittent urinary catheter, with insertion supplies	N	118	118	$902,702
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	19	$10,051
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	68	$4,787
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	N/R	13	$813
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	37	$558

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for David Matthew Paxton, MD?

Tedicare shows public-source Medicare data for David Matthew Paxton, MD (NPI 1578940649), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Matthew Paxton, MD have ACO affiliation data?

David Matthew Paxton, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to David Matthew Paxton, MD?

David Matthew Paxton, MD is linked to WHEELING HOSPITAL INC (billing NPI 1548923923) in the available physician profile data.

Does David Matthew Paxton, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.